Abstract

Cerebral ischemia is clinically characterized by a partial functional neurological deficit, which represents one of the leading causes of death. This study aimed to determine whether rice bran extract (RB), ferulic acid (FA), or rice bran extract supplemented with FA (RB + FA) promote functional recovery from ischemic injury. Focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in rats. Four groups were studied, including (1) vehicle group, (2) RB 5%, 10%, and 20% groups, (3) FA group, and (4) RB + FA group. Animals were injected with RB or FA once a day for 3 days after MCAO. In this study's results, the RB 20% and FA groups significantly improved neurological functions compared with the vehicle group. The RB + FA group produced more recovery from functional deficits than the other groups. Moreover, the RB 20%, FA, and RB + FA groups enhanced the antiapoptotic effect in the cortex and neural cell densities in the hippocampal DG and CA1. The RB 20%, FA, and RB + FA groups stimulated not only the expression of neurotrophic factor and antioxidant genes but also neuronal nuclei (NeuN), synaptophysin, and glutamic acid decarboxylase 67 (GAD67) proteins. Our finding indicates that the combination of RB + FA treatment showed the most synergic effect in functional recovery with ischemic brain through the stimulation of the nuclear factor-E2-related factor 2, brain-derived neurotrophic factor NeuN, SYP, and GAD67 expressions.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.